312 related articles for article (PubMed ID: 12947201)
1. Persistence without pathology in phosphoglycan-deficient Leishmania major.
Späth GF; Lye LF; Segawa H; Sacks DL; Turco SJ; Beverley SM
Science; 2003 Aug; 301(5637):1241-3. PubMed ID: 12947201
[TBL] [Abstract][Full Text] [Related]
2. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
[TBL] [Abstract][Full Text] [Related]
3. Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice.
Kébaïer C; Uzonna JE; Beverley SM; Scott P
Infect Immun; 2006 Jan; 74(1):777-80. PubMed ID: 16369039
[TBL] [Abstract][Full Text] [Related]
4. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
[TBL] [Abstract][Full Text] [Related]
6. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.
Späth GF; Epstein L; Leader B; Singer SM; Avila HA; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9258-63. PubMed ID: 10908670
[TBL] [Abstract][Full Text] [Related]
7. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
Aguilar-Torrentera F; Carlier Y
Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
[TBL] [Abstract][Full Text] [Related]
8. The protective effect against Leishmania infection conferred by sand fly bites is limited to short-term exposure.
Rohoušová I; Hostomská J; Vlková M; Kobets T; Lipoldová M; Volf P
Int J Parasitol; 2011 Apr; 41(5):481-5. PubMed ID: 21310158
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
[TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.
Gaur U; Showalter M; Hickerson S; Dalvi R; Turco SJ; Wilson ME; Beverley SM
Exp Parasitol; 2009 Jul; 122(3):182-91. PubMed ID: 19328787
[TBL] [Abstract][Full Text] [Related]
11. Leishmania sp. isolated from human cases of cutaneous leishmaniasis in Brazil characterized as Leishmania major-like.
Silva Sde O; Wu AA; Evans DA; Vieira LQ; Melo MN
Acta Trop; 2009 Dec; 112(3):239-48. PubMed ID: 19660430
[TBL] [Abstract][Full Text] [Related]
12. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response.
Uzonna JE; Späth GF; Beverley SM; Scott P
J Immunol; 2004 Mar; 172(6):3793-7. PubMed ID: 15004184
[TBL] [Abstract][Full Text] [Related]
14. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production.
Hall LR; Titus RG
J Immunol; 1995 Oct; 155(7):3501-6. PubMed ID: 7561045
[TBL] [Abstract][Full Text] [Related]
15. Virulent and attenuated lines of Leishmania major: DNA karyotypes and differences in metalloproteinase GP63.
Sádlová J; Volf P; Victoir K; Dujardin JC; Votýpka J
Folia Parasitol (Praha); 2006 Jun; 53(2):81-90. PubMed ID: 16898121
[TBL] [Abstract][Full Text] [Related]
16. Histone H1 regulates chromatin condensation in Leishmania parasites.
Masina S; Zangger H; Rivier D; Fasel N
Exp Parasitol; 2007 May; 116(1):83-7. PubMed ID: 17207482
[TBL] [Abstract][Full Text] [Related]
17. Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors.
Svárovská A; Ant TH; Seblová V; Jecná L; Beverley SM; Volf P
PLoS Negl Trop Dis; 2010 Jan; 4(1):e580. PubMed ID: 20084096
[TBL] [Abstract][Full Text] [Related]
18. Leishmania major CorA-like magnesium transporters play a critical role in parasite development and virulence.
Zhu Y; Davis A; Smith BJ; Curtis J; Handman E
Int J Parasitol; 2009 May; 39(6):713-23. PubMed ID: 19136005
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice.
Reiling L; Jacobs T; Kroemer M; Gaworski I; Graefe S; Clos J
Infect Immun; 2006 Nov; 74(11):6027-36. PubMed ID: 17057085
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin is required for Leishmania major stress response pathways and for virulence in the mammalian host.
Naderer T; Dandash O; McConville MJ
Mol Microbiol; 2011 Apr; 80(2):471-80. PubMed ID: 21320183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]